American scientists have discovered a new way to fight brain cancer

American researchers have made a significant breakthrough in the treatment of brain cancer, presenting an innovative method based on dual immunotherapy using modified T cells. This approach aims to strengthen the immune system of patients, which helps slow tumor growth and increase patient survival. The results of the first trials have generated optimism in the scientific community, as patients were able to live significantly longer than previously expected.

During the initial phase of the experiments, according to representatives of the research group, some patients showed an increase in life expectancy of about a year — a figure that was previously considered virtually unattainable. Such results are already being seen as a significant step forward in the fight against one of the most aggressive types of cancer. Doctors emphasize that it is the combination of immunotherapy and genetic modification of T cells that opens up new horizons for therapy.

Further clinical trials conducted on a group of 18 people confirmed the effectiveness of the method: 62 percent of patients showed a significant reduction in tumor size. At the same time, 43 percent of patients were able to live for more than a year after the start of treatment, which in itself is a notable achievement in this field of medicine. Particular attention was drawn to the case of one patient whose tumor stopped growing and stabilized for 16 months — this effect is considered outstanding and gives hope for the further development of similar techniques.

Experts believe that dual immunotherapy, which stimulates the body’s natural defense mechanisms, may in the future become the basis for more effective and less toxic treatments for brain cancer. They note that further research and large-scale clinical trials will help clarify the potential of this method and determine how it can be integrated into standard treatment protocols. Meanwhile, the initial successes are already inspiring scientists and patients, instilling confidence that the fight against this dangerous disease is becoming increasingly realistic.

Kolan Hospital Group Turkey,IstanbulLeave a request

National Cancer Institute Leave a request

Medipol University Hospital Turkey,Istanbul 5.00 (1 review)Leave a request

Published: 21.06.2025

Updated: 22.06.2025

Medical author, Medical editor:

Stepan Yuk

Medical expert:

PhD. Olexandr Voznyak